about
Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort studySerum erythropoietin level and mortality in kidney transplant recipientsMetabolic syndrome over 10 years and cognitive functioning in late midlife: the Whitehall II study.Validating the Framingham Hypertension Risk Score: results from the Whitehall II studyEffect of secular trends on age-related trajectories of cardiovascular risk factors: the Whitehall II longitudinal study 1985-2009.Incremental predictive value of adding past blood pressure measurements to the Framingham hypertension risk equation: the Whitehall II StudyTrajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study.Psychological distress and incidence of type 2 diabetes in high-risk and low-risk populations: the Whitehall II Cohort Study.Association between protein signals and type 2 diabetes incidenceOverall diet history and reversibility of the metabolic syndrome over 5 years: the Whitehall II prospective cohort studyAntidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study.Association between change in body composition and change in inflammatory markers: an 11-year follow-up in the Whitehall II StudyGenetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits.Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.Association of lifecourse socioeconomic status with chronic inflammation and type 2 diabetes risk: the Whitehall II prospective cohort study.Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study.Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study.Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort studySelenium status and blood lipids: the cardiovascular risk in Young Finns study.Lifetime hypertension as a predictor of brain structure in older adults: cohort study with a 28-year follow-up.Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study.Adiposity, obesity, and arterial aging: longitudinal study of aortic stiffness in the Whitehall II cohort[The severity of gestational diabetes mellitus affects microvascular dysfunction measured three years after pregnancy that may be related to increased oxidative stress].Work Disability among Employees with Diabetes: Latent Class Analysis of Risk Factors in Three Prospective Cohort Studies.Change in Sleep Duration and Type 2 Diabetes: The Whitehall II Study.Relationship between serum calcium and CA 19-9 levels in colorectal cancer.Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular DiseaseIndependent and combined effects of physical activity and body mass index on the development of Type 2 Diabetes - a meta-analysis of 9 prospective cohort studies.Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study.Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age.Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance.Does overall diet in midlife predict future aging phenotypes? A cohort study.Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: the Whitehall II prospective cohort study.Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.Hyperglycemia, type 2 diabetes, and depressive symptoms: the British Whitehall II study.Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study.Association between common mental disorder and obesity over the adult life courseMaternal glycemia and risk of large-for-gestational-age babies in a population-based screening.Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study.
P50
Q28728319-8FC3D6AE-469C-4BA1-B90E-591960E3CD43Q30423606-865059E1-CB62-4833-92A3-B9B00C2EBFE5Q33556918-747CD962-346D-4C32-9300-519A40FCCD28Q33687724-6BB69605-8939-4046-A13C-F0511685568DQ33736080-58F68DE3-F3B0-4101-B198-29DDE62C3061Q33820803-DFB2B0E5-3301-4EDE-8CCE-2C7DF000F0F8Q33843643-C4E0F96A-9D54-4E81-8BD6-D0A05ABD188FQ33960237-EF857F2C-2120-494D-92E8-5897F27B9C45Q34152210-7E271769-AA30-4885-A021-89E8D59B04F4Q34237337-FC0D9E84-5F83-43D3-8EEB-E6404C31BD33Q34351813-5A4B043F-8C0D-4963-AFA3-92162A27193FQ34395355-E969AFD5-DC21-4675-BB2A-FAFAD0019AFBQ34545454-C789D564-D365-41A0-9419-F4F38828102DQ34760782-6465A5AC-C444-4978-9465-8F4C6DD19749Q34811767-16CAB779-1A5A-47B2-8137-B1228C329902Q34954456-3755920E-DA17-40D6-8148-5C02787F6BE0Q35059477-DB85954B-7238-4AA4-906F-A63C64B3B978Q35093473-7732B24D-265E-4A94-A80F-19B8084B64A2Q35211152-77C8F125-A143-4610-A900-39BC8C861BF8Q35237351-9CB44E5C-6091-426E-A3AA-926F3D2AE3F1Q35456399-F62978DF-1CB9-413F-BA8E-99413F1974A2Q35794426-49AD2EF7-7BCA-401D-851D-FF22A99E5138Q35815434-D4F9B273-4806-4FDD-A6BB-9A38C709652EQ35841366-D96EF832-E410-4598-9B01-9D9E65F892E3Q35841715-BE83754A-13D2-4B45-A1D1-E59C3671818DQ35881447-EA9CA7B8-8BE0-4642-8099-D76CBF4DB0A7Q36065862-DDCCFC7E-4EB0-4AAA-9A50-7782300222FEQ36141562-145310FB-E496-4ECC-8BC3-3D21E0598EABQ36336774-F3B975C2-F353-407A-A3DB-5152F319E071Q36426822-32D73670-6A54-43D1-9AC2-3BB78957CF0EQ36720395-C7FAC8D7-9766-4D50-AC00-25B5E79B94C1Q37022811-6FE86A1B-EFA1-483C-A770-B9527275F208Q37094297-E14D544A-FDCC-4F28-AD09-06B8FB3C4B62Q37286658-6B15B250-1B21-4418-93C1-295E35580C09Q37304741-20F53E04-46E0-4734-8112-B8CFD9298EA4Q37364941-92E26D18-5A27-4354-9CEF-0AC6EFC0B7EBQ37404531-A9AA8356-8BBA-4583-A1F7-B9A6ACE677B4Q37405175-18C40693-2705-4005-83B8-BD3AA6B3E2A0Q37437091-41AC2A94-463B-43D8-98BA-34E68D28E495Q37475607-DBFD2A5D-ADB8-4359-85EA-50A598430683
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adam G Tabak
@ast
Adam G Tabak
@en
Adam G Tabak
@es
Adam G Tabak
@nl
type
label
Adam G Tabak
@ast
Adam G Tabak
@en
Adam G Tabak
@es
Adam G Tabak
@nl
prefLabel
Adam G Tabak
@ast
Adam G Tabak
@en
Adam G Tabak
@es
Adam G Tabak
@nl
P106
P21
P31
P496
0000-0002-6234-3936